Your session is about to expire
← Back to Search
Balance Training for Fall Prevention
N/A
Recruiting
Led By Michael L Madigan, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a balance training exercise to reduce risk of slips and falls for workers. Participants will complete sessions, answer messages about falls and a subset will participate in focus groups.
Who is the study for?
This trial is for Virginia Tech workers in Dining Services, Facilities and Housekeeping, construction, and Veolia field workers in water distribution and main construction aged between 18-65. They must be willing to complete training sessions, lab testing, and daily falls tracking for 12 weeks. Those over 250 pounds or not cleared by the Physical Activity Readiness Questionnaire cannot join.
What is being tested?
The study tests slip recovery training against an alternative balance training among workers at risk of slipping on the job. Participants will undergo weekly sessions for up to six weeks and report any falls for three months post-training. Some will also attend focus groups to discuss long-term feasibility.
What are the potential side effects?
There are no specific side effects mentioned for this intervention; however, participants may experience discomfort or muscle soreness typical with physical activity or balance exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
efficacy of field assessments of balance
evaluation of recruitment methods
evaluation of screening methods
+6 moreSecondary study objectives
dynamic balance performance
field assessment of peak slip speed
field assessment of slip distance
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Slip recovery trainingExperimental Treatment1 Intervention
Once weekly sessions of slip recovery training for 3 or 6 weeks. Each session will be 20 minutes of training. Training will involve volitional and reactive stepping movements that mimic the movements necessary to recover balance after slipping while walking.
Group II: Alternative balance trainingActive Control1 Intervention
Once weekly sessions of balance training for 3 or 6 weeks. Each session will be 20 minutes of training. Training will involve standing balance under varied sensory conditions, and tandem walking forward and backward under varied sensory conditions.
Find a Location
Who is running the clinical trial?
Virginia Polytechnic Institute and State UniversityLead Sponsor
156 Previous Clinical Trials
25,665 Total Patients Enrolled
Michael L Madigan, PhDPrincipal InvestigatorVirginia Polytechnic Institute and State University
1 Previous Clinical Trials
34 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 65 years old.I am willing to attend training, lab tests, and track falls for 12 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Slip recovery training
- Group 2: Alternative balance training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.